NS · Healthcare

Phaarmasia Ltd (523620)

Pharmaceuticals & Biotechnology

Phaarmasia Ltd (523620) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $686.10M, P/E ratio is 3.90, net margin is 9.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 523620

Market cap

$686.10M

P/E ratio

3.90

Net margin

9.5%

Phaarmasia Ltd (523620) — FAQ

What is Phaarmasia Ltd's market cap?

Phaarmasia Ltd (523620) has a reported market cap of $686.10M (data as of 2026-07-10).

What is 523620's P/E ratio?

The price-to-earnings (P/E) ratio for Phaarmasia Ltd (523620) is 3.90 (data as of 2026-07-10).

Does Phaarmasia Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Phaarmasia Ltd (523620). Check the MyAverix Finance app for the latest dividend data.

What sector is Phaarmasia Ltd in?

Phaarmasia Ltd (523620) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 523620 listed on?

523620 is listed on NS.

What is Phaarmasia Ltd's net margin?

Phaarmasia Ltd (523620) reports a net margin of 9.5% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)